Mozambique women who use modern contraceptives more likely to undergo HIV testing

Women in sub-Saharan Africa who use modern contraceptives are more likely to be tested for HIV than those who do not, according to a study published April 25, 2016 in the open-access journal PLOS ONE by Katherine Center from the University of Arizona and colleagues.

HIV/AIDS remains a major public health challenge for women in sub-Saharan Africa, and medical appointments for use of modern contraceptives could provide an opportunity to offer confidential HIV testing. The authors of the present study analysed data from the Demographic and Health survey for Congo, Mozambique, Nigeria, and Uganda to examine the relationship between use of modern contraceptives and HIV testing in women.

They found that in the total pooled sample and specifically in Mozambique, women who used modern contraceptives, including oral contraceptives and condoms, were more likely to undergo HIV testing than women who relied on traditional contraceptive methods, such as periodic abstinence or withdrawal. However, a low proportion of the overall population in Mozambique was found to use modern contraceptives. This positive association was not seen in the other countries studied but was seen in the pooled total sample.

While this study was limited to a two-year period and cannot show causation between use of modern contraceptives and increased HIV testing, the authors suggest their work highlights a missed opportunity to provide education and HIV testing concurrently with condom and pill provision. The authors propose that integration of HIV testing, counselling, and treatment into family planning programs could help to reduce the burden of HIV in sub-Saharan Africa.



The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthroughs in germline-targeting HIV vaccine design for broad protection